
ArchiMed has acquired a majority stake in Germany-based Zyto Group, a company that develops cancer diagnostic tests and equipment.

ArchiMed has acquired a majority stake in Germany-based Zyto Group, a company that develops cancer diagnostic tests and equipment.
Recent Comments